WallStSmart

Goodrx Holdings Inc (GDRX)vsMiniMed Group, Inc. Common Stock (MMED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 262% more annual revenue ($2.89B vs $796.85M). GDRX leads profitability with a 3.8% profit margin vs -7.3%. GDRX earns a higher WallStSmart Score of 41/100 (D).

GDRX

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 5.5Value: 5.7Quality: 7.0
Piotroski: 5/9Altman Z: 0.47

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GDRXSignificantly Overvalued (-265.6%)

Margin of Safety

-265.6%

Fair Value

$0.61

Current Price

$2.06

$1.45 premium

UndervaluedFair: $0.61Overvalued

Intrinsic value data unavailable for MMED.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GDRX1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

MMED0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

GDRX4 concerns · Avg: 2.8/10
Market CapQuality
$695.43M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.5%3/10

ROE of 4.5% — below average capital efficiency

Profit MarginProfitability
3.8%3/10

3.8% margin — thin

Revenue GrowthGrowth
-1.9%2/10

Revenue declined 1.9%

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : GDRX

The strongest argument for GDRX centers on Price/Book.

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bear Case : GDRX

The primary concerns for GDRX are Market Cap, Return on Equity, Profit Margin. Thin 3.8% margins leave little buffer for downturns.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Key Dynamics to Monitor

GDRX profiles as a value stock while MMED is a turnaround play — different risk/reward profiles.

MMED is growing revenue faster at 13.1% — sustainability is the question.

GDRX generates stronger free cash flow (32M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GDRX scores higher overall (41/100 vs 37/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Goodrx Holdings Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.

Visit Website →

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Want to dig deeper into these stocks?